Valenzano Ken
SVP, Pharmacology & Biology at FOLD
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jul 13, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FOLDAMICUS THERAPEUTICS, INC.SVP, Pharmacology & Biology
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale FOLDPlan not statedAug 25 2014
Sold 12,450 shares at $6.00 ($75k)
Valenzano Ken, VP, Pharmacology & Biology
Sold 19.4% of holdings ($385k position)51,708 shares leftFiling
- 2 Form 4 sale FOLDUnusualNov 25 +92 days
Sold 25,000 shares at $8.00 ($200k)
Valenzano Ken, VP, Pharmacology & Biology
Sold 33.3% of holdings ($600k position)50,000 shares leftFiling
- 3 Form 4 sale FOLDPlan not statedMar 20 +115 days
Sold 13,050 shares at $11.53 ($150k)
Valenzano Ken, VP, Pharmacology & Biology
Sold 20.7% of holdings ($727k position)50,000 shares left1x usual sizeFiling
- 4 Form 4 sale FOLDPlan not statedMar 20 same day
Sold 7,751 shares at $11.77 ($91k)
Valenzano Ken, VP, Pharmacology & Biology
Sold 13.4% of holdings ($680k position)50,000 shares left0.6x usual sizeFiling
- 5 Form 4 sale FOLDPlan not statedApr 15 +26 days
Sold 5,000 shares at $12.50 ($63k)
Valenzano Ken, VP, Pharmacology & Biology
Sold 9.1% of holdings ($688k position)50,000 shares left0.4x usual sizeFiling
- 6 Form 4 sale FOLDUnusualMay 11 +26 days
Sold 13,000 shares at $10.85 ($141k)
Valenzano Ken, SVP, Pharmacology & Biology
Sold 82.9% of holdings ($170k position)2,687 shares left1.3x usual sizeFiling
- 7 Form 4 sale FOLDUnusualJun 22 +42 days
Sold 20,500 shares at $13.85 ($284k)
Valenzano Ken, SVP, Pharmacology & Biology
Sold 42.5% of holdings ($667k position)27,687 shares left1.6x usual sizeFiling
- 8 Form 4 sale FOLDUnusualJul 13 +21 days
Sold 15,000 shares at $15.00 ($225k)
Valenzano Ken, SVP, Pharmacology & Biology
Sold 35.1% of holdings ($640k position)27,687 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2015 | FOLD | SVP, Pharmacology & Biology | Form 4 sale | 15,000 | $225k | 35.1% | Unusual | SEC |
| Jun 22, 2015 | FOLD | SVP, Pharmacology & Biology | Form 4 sale | 20,500 | $284k | 42.5% | Unusual | SEC |
| May 11, 2015 | FOLD | SVP, Pharmacology & Biology | Form 4 sale | 13,000 | $141k | 82.9% | Unusual | SEC |
| Apr 15, 2015 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 5,000 | $63k | 9.1% | Plan not stated | SEC |
| Mar 20, 2015 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 7,751 | $91k | 13.4% | Plan not stated | SEC |
| Mar 20, 2015 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 13,050 | $150k | 20.7% | Plan not stated | SEC |
| Nov 25, 2014 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 25,000 | $200k | 33.3% | Unusual | SEC |
| Aug 25, 2014 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 12,450 | $75k | 19.4% | Plan not stated | SEC |
| Aug 20, 2014 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 7,000 | $38k | 11.9% | Plan not stated | SEC |
| May 24, 2011 | FOLD | VP, Pharmacology & Biology | Form 4 sale | 2,250 | $17k | 56.8% | Unusual | SEC |